Australia's Cochlear reverses losses; lowers earnings outlook

Cochlear

12/06/2025 02:00

** Shares of Cochlear COH.AX rise 0.7% to A$272.34 after having slumped 8.9% earlier in the day

** COH touched lowest level since April 7

** Hearing implant co downgrades earnings guidance to between A$390 million ($253.73 million) and A$400 million for fiscal 2025

** Previous outlook range was A$410mln-A$430 mln; revision reflects slower-than-expected sales growth in 2025

** Cochlear implant units still expected to increase by around 10% for FY25, with growth weighted to the emerging markets

** Stock up 6.5% YTD

($1 = 1.5370 Australian dollars)

(Reporting by Rishav Chatterjee in Bengaluru)

((Rishav.Chatterjee@thomsonreuters.com))